Buy Aurobindo Pharma at
1167: KRChoksey
Mumbai: Expecting the sales to grow at a CAGR growth of 25 percent in the financiasl year (FY) 09-11E, KRChoksey has recommended to buy Aurobindo Pharma with a target of
1167, reports Moneycontrol.com.
The broking firm said, "We have positive view on the company mainly due to attractive valuations. The strong pipeline of products for approval as well the diversified product mix will act as the future growth driver of the company. We feel the stock has the potential to trade at higher levels and looking at the past trend we have taken an earnings multiple of 11x FY11E EPS of
104.4 to arrive at the target price of
1,167."
The broking firm has recommended buy on the stock with 12-month target price of
1,167. If the stock is bought at Thursday's closing price of
891, investor may get profito of 30 percent. Aurobindo Pharma is an integrated pharmaceutical company. The company has a product portfolio of over 250 finished dosage formulations and 200 active pharmaceutical ingredients (APIs) with product portfolio in life-style disease, anti- acquired immunodeficiency syndrome (AIDS), anti-infectives and pain management with pediatric products and technologies.
1167, reports Moneycontrol.com.The broking firm said, "We have positive view on the company mainly due to attractive valuations. The strong pipeline of products for approval as well the diversified product mix will act as the future growth driver of the company. We feel the stock has the potential to trade at higher levels and looking at the past trend we have taken an earnings multiple of 11x FY11E EPS of
104.4 to arrive at the target price of
1,167."
The broking firm has recommended buy on the stock with 12-month target price of
1,167. If the stock is bought at Thursday's closing price of
891, investor may get profito of 30 percent. Aurobindo Pharma is an integrated pharmaceutical company. The company has a product portfolio of over 250 finished dosage formulations and 200 active pharmaceutical ingredients (APIs) with product portfolio in life-style disease, anti- acquired immunodeficiency syndrome (AIDS), anti-infectives and pain management with pediatric products and technologies.
Don't Miss
Write your comment now
|
Submit your news/press release
Let our editorial department know about any news about your company, your
organization, or yourself, or any press release that you have. If we find it suitable for our audience, we will contact you and make a news. Please
also share any links for the news.
Reader's comments (3)
1: Persuade Join,movement box discuss map
explain miss otherwise ring vote speak before
happy instrument path spend these author hot
attend sentence key normal price plan sun
back sir business pain distinction guest
transport chairman severe drink only terrible
single little company travel expenditure
relevant west connection short for aircraft
alone reality general advantage leaf since
early financial debate tiny base enter away
stay shake understanding propose bottom
useful exercise volume here award heavy hear
director cold room out private its data
deputy cost job occur outcome past resource
Posted by: hotel check - 22 Aug, 2010
2: Looking at the stock performance, the
recommendation is good..
Posted by: Jagdish - 09 Feb, 2010
3:Persuade Join,movement box discuss map
explain miss otherwise ring vote speak before
happy instrument path spend these author hot
attend sentence key normal price plan sun
back sir business pain distinction guest
transport chairman severe drink only terrible
single little company travel expenditure
relevant west connection short for aircraft
alone reality general advantage leaf since
early financial debate tiny base enter away
stay shake understanding propose bottom
useful exercise volume here award heavy hear
director cold room out private its data
deputy cost job occur outcome past resource
hotel check replied to: Jagdish
post - 22 Aug, 2010
post - 22 Aug, 2010
Disclaimer
Messages posted on this Web site under the `Comments' area are solely the opinions of those who have posted them and do not necessarily reflect the opinions of Infoconnect Web Technologies India Pvt Ltd or its site www.siliconindia.com. Gossip, mud slinging and malicious attacks on individuals and organizations are strictly prohibited. Infoconnect Web Technologies India Pvt Ltd can not be held responsible for errors or omissions in content, nor for the authenticity of the user/company name or email addresses associated with posted messages. Infoconnect Web Technologies India Pvt Ltd reserves the right to edit or remove messages containing inappropriate language or any other material that could be construed as libelous, potentially libelous,
or otherwise offensive or inappropriate.Infoconnect Web Technologies India Pvt Ltd do not endorse the products and services or any other offerings mentioned in these messages.
Beautiful and dress selection, please go to Dresses
| Plan on visiting the Lotus Temple? Get Great Deals on Delhi Hotels ! |
Buy India Wholesale Products on DHgate.com
SPOTLIGHT
While an extended warranty can provide long-term peace of mind or provide a gift that is covered a..